Featured

First dengue bout can be as severe as secondary infection: Study

The first bout of dengue can be as life-threatening as the subsequent ones, according to a study published recently in the journal Nature Medicine. The study has analysed severe dengue cases in a group of children in India, showing that more than half could be attributed to primary rather than secondary infection.

The study has challenged the widely held belief that the viral disease is severe only in secondary infections. Over the past two decades, dengue infections have greatly increased in India and the country has one of the largest number of cases globally.

Dengue patients fall into two categories — those experiencing the infection for the first time, known as primary infections and those who get re-infected after a previous exposure, known as secondary infections. The prevailing belief has been that only secondary infections pose significant risks, leading much of the research into vaccine development and treatment to focus on this group.

An international team led by researchers at the New Delhi-based International Centre for Genetic Engineering and Biotechnology (ICGEB) has now found that it is not just the secondary infections but primary ones as well which can be severe and could jeopardise the life of the patients. The finding emphasises the need to re-evaluate the understanding

of dengue and the strategies employed to combat the viral disease cause by the dengue virus (DENV), transmitted to humans through the bite of infected mosquitoes.

“Dengue virus infection is a huge public health problem in India. Many patients develop severe disease that can also be sometimes fatal,” said lead author of the study, Anmol Chandele, from ICGEB. “However, much of the ongoing vaccine intervention research is based on the currently widely held global belief that primary dengue infections are not usually dangerous and that the severe dengue disease is mainly due to secondary infections,” Chandele said.

Medlarge

Recent Posts

ICMR starts first in-human clinical trials for Zika vaccine

The Indian Council of Medical Research (ICMR) has inked agreements with multiple stakeholders for the…

2 months ago

Akums Drugs gest patent for oral suspension of Hydroxyurea for Sickle Cell Disease

Pharma major Akums Drugs and Pharmaceuticals has secured a patent for its Room Temperature Stable…

2 months ago

NITI Ayog suggests separate legislation, fund for future pandemic

A report by an expert group set up by NITI Aayog report titled ‘Future Pandemic…

2 months ago

Health ministry seeks action-taken report from hospitals on Kolkata incident

The union health ministry has sought an action taken report from State governments and Union…

2 months ago

Jupiter hospital drives future of Healthcare Management with JASPER 2024

Jupiter Hospital, a leading tertiary care provider in Pune, recently hosted the Jupiter Administration Symposium…

2 months ago

Mock drill held on pandemic preparedness under National One Health Mission

Under the aegis of National One Health Mission (NOHM), a comprehensive national mock drill, "Vishanu…

2 months ago